Literature DB >> 27397022

Assessment of Added Value of Noncontrast to Contrast-Enhanced Abdominal Computed Tomography Scan for Characterization of Hypervascular Liver Metastases.

Gelareh Sadigh1, Sadhna B Nandwana2, Courtney Moreno2, Kelly L Cox2, Deborah A Baumgarten2, Jeffrey Switchenko3, Tiffany Easter2, Kimberly E Applegate4.   

Abstract

Assess the added value of nonenhanced computed tomography (NECT) to contrast-enhanced CT (CECT) of the abdomen for characterization of hypervascular liver metastases and incidental findings. Institutional review board approved, Health Insurance Probability and Accountability Act compliant, retrospective study of patients with melanoma, neuroendocrine tumor, or thyroid cancer. First available triphasic abdomen CT after initial diagnosis was reviewed by 3 radiologists. The 3 most suspicious lesions were characterized on the CECT as benign or malignant and then recharacterized after reviewing the NECT with CECT. Incidental renal and adrenal lesions were characterized similarly. Diagnostic performance of CECT vs its combination with NECT was assessed. Statistical significance level was set at P < 0.05. A total of 81 patients were included (mean age = 55 years; 52% male; 64% with liver lesions; 27% and 11% with incidental renal and adrenal lesions, respectively). Percentage area under the curve and 95% CI of CECT vs combination with NECT for characterization of liver metastases was 98(94-100) vs 99(96-100) for reviewer 1 (P = 0.35), 93(86-100) vs 94(87-100) for reviewer 2 (P = 0.23), and 96(90-100) vs 99(97-100) for reviewer 3 (P = 0.32). Mean difference in area under the curve and 95% CI between 2 protocols for characterization of liver, renal, and adrenal lesions were -0.007(-0.05 to 0.04) (P = 0.63), -0.09(-0.25 to 0.07) (P = 0.22), and -0.01(-0.05 to 0.02) (P = 0.27), respectively. After addition of NECT, confidence level for lesion characterization increased 4%-15% for liver metastases, 18%-59% and 33%-67% for renal and adrenal lesions, respectively. In conclusion, while addition of NECT to CECT improved radiologist' confidence, there was no statistically significant change in characterization of hypervascular liver metastases or incidental renal and adrenal lesions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27397022      PMCID: PMC5655799          DOI: 10.1067/j.cpradiol.2016.05.003

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  21 in total

1.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

2.  Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose?

Authors:  Frank E Luke; Brian C Allen; Sara T Moshiri; Lisa M Ho; Christopher M Massey; Sandra S Stinnett; Andrew J Muir; Tracy A Jaffe
Journal:  J Comput Assist Tomogr       Date:  2013 May-Jun       Impact factor: 1.826

Review 3.  Management of adrenal incidentaloma.

Authors:  F Menegaux; N Chéreau; J-L Peix; N Christou; J-C Lifante; N C Paladino; F Sebag; C Ghander; C Trésallet; M Mathonnet
Journal:  J Visc Surg       Date:  2014-08-13       Impact factor: 2.043

4.  Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment.

Authors:  Lei Zhang; Lin Yao; Xuesong Li; Michael A S Jewett; Zhisong He; Liqun Zhou
Journal:  J Formos Med Assoc       Date:  2015-06-06       Impact factor: 3.282

5.  Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee.

Authors:  Lincoln L Berland; Stuart G Silverman; Richard M Gore; William W Mayo-Smith; Alec J Megibow; Judy Yee; James A Brink; Mark E Baker; Michael P Federle; W Dennis Foley; Isaac R Francis; Brian R Herts; Gary M Israel; Glenn Krinsky; Joel F Platt; William P Shuman; Andrew J Taylor
Journal:  J Am Coll Radiol       Date:  2010-10       Impact factor: 5.532

6.  Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis.

Authors:  Riccardo Iannaccone; Andrea Laghi; Carlo Catalano; Plinio Rossi; Filippo Mangiapane; Takamichi Murakami; Masatoshi Hori; Francesca Piacentini; Italo Nofroni; Roberto Passariello
Journal:  Radiology       Date:  2005-02       Impact factor: 11.105

7.  CT of melanoma liver metastases: is the examination without contrast media superfluous?

Authors:  J J Chomyn; E R Stamm; D Thickman
Journal:  J Comput Assist Tomogr       Date:  1992 Jul-Aug       Impact factor: 1.826

8.  Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection?

Authors:  J H Oliver; R L Baron; M P Federle; B C Jones; R Sheng
Journal:  Radiology       Date:  1997-12       Impact factor: 11.105

9.  Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms.

Authors:  F H Miller; R S Butler; F L Hoff; S W Fitzgerald; A A Nemcek; R M Gore
Journal:  AJR Am J Roentgenol       Date:  1998-09       Impact factor: 3.959

Review 10.  Imaging management of incidentally detected small renal masses.

Authors:  V Anik Sahni; Stuart G Silverman
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.